Wiley, Acta Psychiatrica Scandinavica, 6(131), p. 408-416, 2014
DOI: 10.1111/acps.12381
Full text: Download
This study aimed at investigating whether dose is a mediator of treatment effect in fluoxetine-randomized trials. Specifically, we investigated whether dose was higher in trials in which the aim was to demonstrate fluoxetine efficacy in comparison with older antidepressants and lower in trials in which the aim was to demonstrate a new drug's efficacy against fluoxetine.